Jump to main content.

Development Document for Proposed Effluent Limitations Guidelines, New Source Performance Standards and Pretreatment Standards for the Pharmaceutical Manufacturing Point Source Category. (See EPA 440-1-82-084).

Quick Links

EPA Office

Ref. Number

Document Type

Title (Downloadable)

Title

Assessment Topic

This document presents the findings of a study of the Pharmaceutical Manufacturing Point Source Category for the purpose of developing effluent limitations guidelines for existing and new point sources and to establish pretreatment standards for existing and new dischargers to publicly owned treatment works to implement Sections 301, 304, 306, 307, 308 and 501 of the Clean Water Act (the Federal Water Pollution Control Act Amendments of 1972, 33 USC 125) et. seq., as amended by the Clean Water Act of 1977, P.L. 95-217 (the "Act")).

Descriptors:
Date:
Reference #:
1982
W.82.20 B
Availability:
Yes
EPA Office:
Office of Water
Office Suboffice:
Effluent Guidelines Division
Office Division:
Office of Water Regulations and Standards
EPA Author:
Hund, Frank H.; Lent, Daniel S.; Vitalis, Joseph S.
Document Type:
Background Cost-Related Document
Contractors:
Document Status:
Not Reported
Pages:
253

Local Navigation


Jump to main content.